Myriad Genetics Inc. (MYGN)
NASDAQ · Healthcare
Myriad Genetics Inc. Long Term Debt 2009–2025
Myriad Genetics Inc. annual/quarterly long term debt history from 2017 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Myriad Genetics Inc. long term debt for the quarter ending December 31, 2025 were 119.9M, a 202.78% increase year-over-year.
- Myriad Genetics Inc. long term debt for 2025 were 119.9M, a 202.78% increase from 2024.
- Myriad Genetics Inc. long term debt for 2024 were 39.6M, a 2.86% increase from 2023.
- Myriad Genetics Inc. long term debt for 2023 were 38.5M, a 82.87% decrease from 2020.
- Myriad Genetics Inc. long term debt for 2020 were 224.8M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Myriad Genetics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $120 |
| 2024 | $40 |
| 2023 | $39 |
| 2020 | $225 |
| 2019 | $234 |
| 2018 | $9 |
| 2017 | $99 |
| Myriad Genetics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $120 |
| 2024-12-31 | $40 |
| 2023-12-31 | $39 |
| 2020-12-31 | $225 |
| 2020-06-30 | $224 |
| 2019-06-30 | $234 |
| 2018-06-30 | $9 |
| 2017-06-30 | $99 |
Myriad Genetics Inc. Long Term Debt — FAQ
Myriad Genetics Inc. (MYGN) long term debt over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MYGN's long term debt history?
The chart and table above show Myriad Genetics Inc.'s long term debt by year and by quarter, including the growth rate.